TMO.NEO Thermo Fisher CDR (CAD Hedged)

Healthcare Diagnostics & Research NEO Exchange
24.71 CAD
Close of Oct 30, 2026
15.71 25.16
Market cap
CAD 347B
P/E
38.0x
P/B
4.36x
ROE
12.9%
Dividend yield
0.30%
Fundamental score
1.6/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is TMO.NEO undervalued?

Graham number
Price24.71
Graham value9.11
Premium171.3%

TMO.NEO trades 171.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Thermo Fisher CDR (CAD Hedged) fundamental analysis

8 of 22 checks passed

ROE 1/2

Moderate return on equity (12.9%), between 10% and 20%.

ROA 1/1

Return on assets (6.0%) is above the industry median (5.5%).

Profit Consistency 2/2

Profitable for 5 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (7.1%) is below the industry median (33.8%).

Revenue Growth 0/2

Revenue shrank 0.3% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 0/1

Current assets do not cover long-term liabilities.

Debt to Equity 1/2

Moderate debt to equity (74.4%), up to 100%.

Debt Trend 0/1

Debt to equity history is shorter than 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 1/1

EBIT is 5.8x against interest expense, well covered.

PE vs Market 0/1

PE (38.7x) is above the market median (20.3x).

PE vs Industry 0/1

PE (38.7x) is above the industry median (20.3x).

PBV 0/1

Price to book (4.4x) is above the industry median (2.5x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 171.7, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

Dividend yield (0.2%) is in the bottom 25% of dividend payers in the market.

Dividend Stability 1/2

Dividends paid without a cut of more than 10% for 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 1/1

Payout ratio is 9.5%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Thermo Fisher CDR (CAD Hedged) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Thermo Fisher CDR (CAD Hedged)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments seg…

Full company profile